Chart calendar Gilead Sciences, Inc.

c40e897ef6ad3cb0a5.cdQ6zhNhd7k_OpKcp42OmZQzUpwSbpbpvR_MSfmiLus.GYRP-SYjNIB4SeTdkLz50vBcJt8hOOK410a9I5XkSb4E5wqjZxsAi0tu-Q~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

2026-02-09

Q4 2025 Earnings Release (Projected)

2026-04-22

Q1 2026 Earnings Release (Projected)

2026-07-29

Q2 2026 Earnings Release (Projected)

2026-10-28

Q3 2026 Earnings Release (Projected)

Past events on Gilead Sciences, Inc.

2025-12-14

Ex-dividend day

2025-12-08

American Society of Hematology Meeting - Abstract #6284

2025-12-08

American Society of Hematology Meeting - Abstract #6344

2025-12-08

American Society of Hematology Meeting - Abstract #5882

2025-12-08

American Society of Hematology Meeting - Abstract #5356

2025-12-08

American Society of Hematology Meeting - Abstract #6194

2025-12-08

American Society of Hematology Meeting - Abstract #805

2025-12-07

American Society of Hematology Meeting - Abstract #3717

2025-12-07

American Society of Hematology Meeting - Abstract #4411

2025-12-07

American Society of Hematology Meeting - Abstract #3606

2025-12-07

American Society of Hematology Meeting - Abstract #4503

2025-12-07

American Society of Hematology Meeting - Abstract #4510

2025-12-07

American Society of Hematology Meeting - Abstract #3714

2025-12-07

American Society of Hematology Meeting - Abstract #671

2025-12-07

American Society of Hematology Meeting - Abstract #569

2025-12-07

American Society of Hematology Meeting - Abstract #203

2025-12-06

American Society of Hematology Meeting - Abstract #1799

2025-12-06

American Society of Hematology Meeting - Abstract #1588

2025-12-06

American Society of Hematology Meeting - Abstract #1894

2025-12-06

American Society of Hematology Meeting - Abstract #1799

Past dividends on Gilead Sciences, Inc.

2025-12-14

Quarterly 0.79 USD

2025-09-14

Quarterly 0.79 USD

2025-06-12

Quarterly 0.79 USD

2025-03-13

Quarterly 0.79 USD

2024-12-12

Quarterly 0.77 USD

2024-09-12

Quarterly 0.77 USD

2024-06-13

Quarterly 0.77 USD

2024-03-13

Quarterly 0.77 USD

2023-12-13

Quarterly 0.75 USD

2023-09-13

Quarterly 0.75 USD

2023-06-13

Quarterly 0.75 USD

2023-03-13

Quarterly 0.75 USD

2022-12-13

Quarterly 0.73 USD

2022-09-13

Quarterly 0.73 USD

2022-06-13

Quarterly 0.73 USD

2022-03-13

Quarterly 0.73 USD

2021-12-13

Quarterly 0.71 USD

2021-09-13

Quarterly 0.71 USD

2021-06-13

Quarterly 0.71 USD

2021-03-11

Quarterly 0.71 USD

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million USD
Released
Forecast
Spread
27 281
26 518
2.88%
27 116
27 083
0.12%
28 754
28 310
1.57%

29 210


30 132


31 560

EBITDA
Million USD
Released
Forecast
Spread
14 283
13 783
3.63%
13 177
13 123
0.41%
11 287
10 600
6.49%

15 978


16 554


17 244

EBIT
Million USD
Released
Forecast
Spread
12 180
12 141
0.32%
10 484
10 687
-1.9%
8 520
8 238
3.42%

13 321


14 146


14 999

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 814
5 658
2.76%
6 859
7 323
-6.33%
690
498
38.57%

10 022


10 871


11 502

Net income
Million USD
Released
Forecast
Spread
4 592
4 383
4.77%
5 665
5 872
-3.52%
480
282
70.44%

8 283


8 946


9 628

EPS
USD
Released
Forecast
Spread
3,64
3,48
4.75%
4,50
4,69
-3.96%
0,38
0,10
274.46%

6,86


7,49


8,07

Announcement Date02/02/2306/02/2411/02/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million USD
Released
Forecast
Spread
6 686
6 349
5.31%
6 954
6 735
3.25%
7 545
6 999
7.8%
7 569
7 154
5.8%
6 667
6 823
-2.29%
7 082
6 964
1.69%
7 769
7 459
4.16%

7 673


7 039


7 492


7 743


8 143

EBITDA
Million USD
Released
Forecast
Spread
-427
-889
51.98%
3 959
3 365
17.67%
3 948
3 498
12.86%
3 807
3 255
16.94%
3 589
3 423
4.85%
3 981
4 110
-3.13%
4 607
4 587
0.44%

4 390


3 931


4 203


4 375


4 500

EBIT
Million USD
Released
Forecast
Spread
-1 117
-1 679
33.48%
3 265
2 739
19.18%
3 258
2 721
19.75%
3 114
2 876
8.27%
2 893
2 825
2.4%
3 290
3 235
1.71%
3 921
3 482
12.6%

3 159


3 197


3 491


3 723


3 824

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-4 486


2 053
1 733
18.45%
956
1 652
-42.12%
2 168
2 043
6.14%
1 649
2 068
-20.24%
2 429
2 355
3.14%
3 641
2 628
38.56%

2 338


2 603


3 187


2 827


2 950

Net income
Million USD
Released
Forecast
Spread
-4 170
-2 888
-44.38%
1 614
1 379
17.02%
1 253
1 335
-6.15%
1 783
1 605
11.1%
1 315
1 546
-14.92%
1 960
1 898
3.24%
3 052
2 098
45.48%

1 915


2 078


2 435


2 394


2 410

EPS
USD
Released
Forecast
Spread
-3,34
-1,92
-74.06%
1,29
1,13
14.13%
1,00
1,08
-7.48%
1,42
1,19
19.08%
1,04
1,26
-17.23%
1,56
1,48
5.12%
2,43
1,69
43.48%

1,60


1,62


1,87


1,97


1,95

Announcement Date25/04/2408/08/2406/11/2411/02/2524/04/2507/08/2530/10/25-----
2026-01-05

Q3 2025 Earnings Release

2026-01-11

Q2 2026 Earnings Release (Projected)

2026-01-15

Q3 2026 Earnings Release (Projected)

2026-01-20

Q4 2025 Earnings Release

2026-01-20

Q4 2025 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-21

Q3 2026 Earnings Release (Projected)

2026-01-22

Q3 2026 Earnings Release (Projected)

2026-01-26

Q3 2026 Earnings Release (Projected)

More events

Past sector events for Gilead Sciences, Inc.

2025-12-10

November 2025 Sales and Revenue Release

2025-12-10

November 2025 Sales and Revenue Release

2025-12-09

Q2 2026 Earnings Release

2025-12-09

November 2025 Sales and Revenue Release

2025-12-09

November 2025 Sales and Revenue Release

2025-12-05

November 2025 Sales and Revenue Release

2025-11-30

Q3 2025 Earnings Release

2025-11-27

Q2 2026 Earnings Release

2025-11-19

Q3 2025 Earnings Release

2025-11-14

Q2 2026 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GILD Stock
  4. Calendar Gilead Sciences, Inc.